Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
出版年份 2018 全文链接
标题
Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 33, Pages 3695-3708
出版商
Baishideng Publishing Group Inc.
发表日期
2018-09-06
DOI
10.3748/wjg.v24.i33.3695
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
- (2018) Oriana Lo Re et al. HEPATOLOGY
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
- (2017) Wenxia Shi et al. MEDICINE
- Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
- (2017) Conor A. Bradley et al. Nature Reviews Clinical Oncology
- Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
- (2017) Chao-Yue Sun et al. Oncotarget
- Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma
- (2017) Andrew X. Zhu et al. JAMA Oncology
- Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
- (2017) Benjamin Owusu et al. Cancers
- The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
- (2017) Chi-Tan Hu et al. Cancers
- A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
- (2016) W. M. Tai et al. ANNALS OF ONCOLOGY
- Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway
- (2016) Bin Jin et al. BMC CANCER
- Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations
- (2016) Christoph A. Thaiss et al. CELL
- Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE 2 pathway
- (2016) Zexin Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
- (2016) Zhen Qu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets
- (2016) N A Wijetunga et al. ONCOGENE
- Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
- (2016) Ahmed Kaseb et al. OncoTargets and Therapy
- MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer
- (2016) Yongbing Chen et al. Oncotarget
- MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
- (2016) Ming-Hua Hu et al. Oncotarget
- Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing
- (2016) Davide Degli Esposti et al. Oncotarget
- Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling
- (2016) Eunice Yuen Ting Lau et al. Cell Reports
- c-Met identifies a population of matrix metalloproteinase 9-producing monocytes in peritumoural stroma of hepatocellular carcinoma
- (2015) Lan Zhao et al. JOURNAL OF PATHOLOGY
- Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity
- (2015) J.-C. Jo et al. MOLECULAR CANCER THERAPEUTICS
- The Landscape of long noncoding RNA classification
- (2015) Georges St. Laurent et al. TRENDS IN GENETICS
- MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma
- (2015) Wei Ding et al. TUMOR BIOLOGY
- EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
- (2015) John E. Campbell et al. ACS Medicinal Chemistry Letters
- Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction
- (2015) Yoon Mee Yang et al. Oncotarget
- MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A
- (2015) Katsuya Ohta et al. Oncotarget
- Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
- (2015) Javier A. García-Vilas et al. Scientific Reports
- miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met
- (2014) Peyda Korhan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The functional role of long non-coding RNAs and epigenetics
- (2014) Jinneng Cao BIOLOGICAL PROCEDURES ONLINE
- MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
- (2014) Jian-Ya Zhou et al. CANCER LETTERS
- An Inducible Hepatocellular Carcinoma Model for Preclinical Evaluation of Antiangiogenic Therapy in Adult Mice
- (2014) A. Runge et al. CANCER RESEARCH
- Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET
- (2014) Q. Xiang et al. CLINICAL CANCER RESEARCH
- Role of MicroRNAs in Hepatocellular Carcinoma
- (2014) Zixiang Zhu et al. Hepatitis Monthly
- FAK Is required for c-Met/β-catenin-driven hepatocarcinogenesis
- (2014) Na Shang et al. HEPATOLOGY
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
- (2014) Shu-Bin Gao et al. JOURNAL OF HEPATOLOGY
- Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
- (2014) Makiko Kawaguchi et al. Cancers
- The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
- (2014) Friedhelm Bladt et al. Cancers
- The emerging role of MET/HGF inhibitors in oncology
- (2013) Giorgio V. Scagliotti et al. CANCER TREATMENT REVIEWS
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Targeting MET: why, where and how?
- (2013) Elena Ghiso et al. CURRENT OPINION IN PHARMACOLOGY
- Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes
- (2013) Mizuho Nakayama et al. CYTOKINE
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway
- (2013) Xin Yang et al. HEPATOLOGY
- MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
- (2013) Xin Yang et al. HEPATOLOGY
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- Targeted therapy of hepatocellular carcinoma: Present and future
- (2012) Stephen L Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis
- (2012) Giray Bozkaya et al. Molecular Cancer
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacokinetic drivers of toxicity for basic molecules: Strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor
- (2012) Dolores Diaz et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met
- (2011) Zheng-sheng Wu et al. CANCER
- MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer
- (2011) B. Zheng et al. CLINICAL CANCER RESEARCH
- VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
- (2011) Apostolos C. Ziogas et al. INTERNATIONAL JOURNAL OF CANCER
- Functional analysis of microRNAs in human hepatocellular cancer stem cells
- (2011) Fanyin Meng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolism
- (2011) Arlee Fafalios et al. NATURE MEDICINE
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Tumor-Associated Lymphangiogenesis Correlates with Prognosis after Resection of Human Hepatocellular Carcinoma
- (2009) Armin Thelen et al. ANNALS OF SURGICAL ONCOLOGY
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
- (2008) Maresa Caunt et al. CANCER CELL
- Molecular cancer therapy: Can our expectation be MET?
- (2008) Cristina Migliore et al. EUROPEAN JOURNAL OF CANCER
- Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
- (2008) Pankaj K. Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer
- (2008) Mohd W. Nasser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAmiR-199a*Regulates theMETProto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)
- (2008) Seonhoe Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Direct Interaction between SET8 and Proliferating Cell Nuclear Antigen Couples H4-K20 Methylation with DNA Replication
- (2008) Michael S. Y. Huen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started